Is there a link between very early changes of primary and secondary lymphoid organs in 18F-FDG-PET/MRI and treatment response to checkpoint inhibitor therapy?
Trial registration number NCT03132090, DRKS00013925.
Saved in:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-10-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/8/2/e000656.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846171546194804736 |
|---|---|
| author | Konstantin Nikolaou Andrea Forschner Benjamin Weide Claus Garbe Christina Pfannenberg Ahmed E Othman Johannes Schwenck Christian la Fougère Ferdinand Seith Brigitte Gückel Martin Schwartz Matthias Fenchel Nina Schwenzer |
| author_facet | Konstantin Nikolaou Andrea Forschner Benjamin Weide Claus Garbe Christina Pfannenberg Ahmed E Othman Johannes Schwenck Christian la Fougère Ferdinand Seith Brigitte Gückel Martin Schwartz Matthias Fenchel Nina Schwenzer |
| author_sort | Konstantin Nikolaou |
| collection | DOAJ |
| description | Trial registration number NCT03132090, DRKS00013925. |
| format | Article |
| id | doaj-art-d3b8123f2f8943e2a6f15f6c1afa8cba |
| institution | Kabale University |
| issn | 2051-1426 |
| language | English |
| publishDate | 2020-10-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj-art-d3b8123f2f8943e2a6f15f6c1afa8cba2024-11-10T13:35:08ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262020-10-018210.1136/jitc-2020-000656Is there a link between very early changes of primary and secondary lymphoid organs in 18F-FDG-PET/MRI and treatment response to checkpoint inhibitor therapy?Konstantin Nikolaou0Andrea Forschner1Benjamin Weide2Claus Garbe3Christina Pfannenberg4Ahmed E Othman5Johannes Schwenck6Christian la Fougère7Ferdinand Seith8Brigitte Gückel9Martin Schwartz10Matthias Fenchel11Nina Schwenzer12Image-guided and Functionally Instructed Tumor Therapies (iFIT), The Cluster of Excellence 2180, Tuebingen, GermanyCenter for Dermatooncology, Department of Dermatology, Eberhard-Karls University of Tübingen, Tubingen, GermanyDepartment of Dermatology, University Hospital Tübingen, Eberhard Karls University of Tübingen, Tübingen, Germany19 Department of Dermatology, Eberhard Karls Universitat Tübingen, Tübingen, Baden-Württemberg, GermanyDepartment of Radiology, University of Tuebingen, Tuebingen, GermanyDpt. of Neuroradiology, University Medical Center of the Johannes Gutenberg University, Mainz, Germany3 0000 0001 2190 1447grid.10392.39Cluster of Excellence iFIT (EXC2180) “Image-Guided and Functionally Instructed Tumor Therapies”University of Tübingen Tubingen Germany11 0000 0001 0196 8249grid.411544.1Department of Nuclear Medicine and Clinical Molecular ImagingUniversity Hospital of Tübingen Tübingen Germany1 Diagnostic and Interventional Radiology, Eberhard Karls University Tübingen, Tübingen, Germany1 Diagnostic and Interventional Radiology, Eberhard Karls University Tübingen, Tübingen, Germany3 Section on Experimental Radiology, Eberhard Karls University Tübingen, Tubingen, Germany7 Diagnostic Imaging, Magnetic Resonance, Siemens Healthcare GmbH, Erlangen, Bayern, Germany1 Diagnostic and Interventional Radiology, Eberhard Karls University Tübingen, Tübingen, GermanyTrial registration number NCT03132090, DRKS00013925.https://jitc.bmj.com/content/8/2/e000656.full |
| spellingShingle | Konstantin Nikolaou Andrea Forschner Benjamin Weide Claus Garbe Christina Pfannenberg Ahmed E Othman Johannes Schwenck Christian la Fougère Ferdinand Seith Brigitte Gückel Martin Schwartz Matthias Fenchel Nina Schwenzer Is there a link between very early changes of primary and secondary lymphoid organs in 18F-FDG-PET/MRI and treatment response to checkpoint inhibitor therapy? Journal for ImmunoTherapy of Cancer |
| title | Is there a link between very early changes of primary and secondary lymphoid organs in 18F-FDG-PET/MRI and treatment response to checkpoint inhibitor therapy? |
| title_full | Is there a link between very early changes of primary and secondary lymphoid organs in 18F-FDG-PET/MRI and treatment response to checkpoint inhibitor therapy? |
| title_fullStr | Is there a link between very early changes of primary and secondary lymphoid organs in 18F-FDG-PET/MRI and treatment response to checkpoint inhibitor therapy? |
| title_full_unstemmed | Is there a link between very early changes of primary and secondary lymphoid organs in 18F-FDG-PET/MRI and treatment response to checkpoint inhibitor therapy? |
| title_short | Is there a link between very early changes of primary and secondary lymphoid organs in 18F-FDG-PET/MRI and treatment response to checkpoint inhibitor therapy? |
| title_sort | is there a link between very early changes of primary and secondary lymphoid organs in 18f fdg pet mri and treatment response to checkpoint inhibitor therapy |
| url | https://jitc.bmj.com/content/8/2/e000656.full |
| work_keys_str_mv | AT konstantinnikolaou istherealinkbetweenveryearlychangesofprimaryandsecondarylymphoidorgansin18ffdgpetmriandtreatmentresponsetocheckpointinhibitortherapy AT andreaforschner istherealinkbetweenveryearlychangesofprimaryandsecondarylymphoidorgansin18ffdgpetmriandtreatmentresponsetocheckpointinhibitortherapy AT benjaminweide istherealinkbetweenveryearlychangesofprimaryandsecondarylymphoidorgansin18ffdgpetmriandtreatmentresponsetocheckpointinhibitortherapy AT clausgarbe istherealinkbetweenveryearlychangesofprimaryandsecondarylymphoidorgansin18ffdgpetmriandtreatmentresponsetocheckpointinhibitortherapy AT christinapfannenberg istherealinkbetweenveryearlychangesofprimaryandsecondarylymphoidorgansin18ffdgpetmriandtreatmentresponsetocheckpointinhibitortherapy AT ahmedeothman istherealinkbetweenveryearlychangesofprimaryandsecondarylymphoidorgansin18ffdgpetmriandtreatmentresponsetocheckpointinhibitortherapy AT johannesschwenck istherealinkbetweenveryearlychangesofprimaryandsecondarylymphoidorgansin18ffdgpetmriandtreatmentresponsetocheckpointinhibitortherapy AT christianlafougere istherealinkbetweenveryearlychangesofprimaryandsecondarylymphoidorgansin18ffdgpetmriandtreatmentresponsetocheckpointinhibitortherapy AT ferdinandseith istherealinkbetweenveryearlychangesofprimaryandsecondarylymphoidorgansin18ffdgpetmriandtreatmentresponsetocheckpointinhibitortherapy AT brigitteguckel istherealinkbetweenveryearlychangesofprimaryandsecondarylymphoidorgansin18ffdgpetmriandtreatmentresponsetocheckpointinhibitortherapy AT martinschwartz istherealinkbetweenveryearlychangesofprimaryandsecondarylymphoidorgansin18ffdgpetmriandtreatmentresponsetocheckpointinhibitortherapy AT matthiasfenchel istherealinkbetweenveryearlychangesofprimaryandsecondarylymphoidorgansin18ffdgpetmriandtreatmentresponsetocheckpointinhibitortherapy AT ninaschwenzer istherealinkbetweenveryearlychangesofprimaryandsecondarylymphoidorgansin18ffdgpetmriandtreatmentresponsetocheckpointinhibitortherapy |